Measuring Communication in Microbial Biofilms in Response to Antibiotics, Phytochemicals and Stressors. [PDF]
Zingg JM +7 more
europepmc +1 more source
Intracranial glioma xenograft model rapidly reestablishes blood–brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents [PDF]
Achilefu, Samuel +9 more
core +1 more source
The introduction outlines the review scope. Microbial cell factories as living drugs cover host–gut microbiota, bacteria, yeast, and other microbial systems, with comparative host advantages. Engineering strategies include synthetic circuits, quorum sensing, and memory.
Cemile Elif Özçelik +3 more
wiley +1 more source
Absence of the luciferase gene in the genome of the kleptoprotein bioluminescent fish Parapriacanthus ransonneti. [PDF]
Bessho-Uehara M +5 more
europepmc +1 more source
Abstract Accurate quantification of chimeric antigen receptor (CAR) T cells is essential for monitoring post‐infusion CART expansion and persistence and for real‐time clinical decision‐making. Multiparameter flow cytometry (MFC) enables rapid, live‐cell detection with absolute quantification and concurrent immunophenotypic characterization. This review
Jianhua Ling, Wei Wang, Sa A. Wang
wiley +1 more source
Resveratrol and dexamethasone have cell-specific effects on the circadian clock but not on the rhythm of mitochondrial function in the fetal heart. [PDF]
Semenovykh D +3 more
europepmc +1 more source
Scheme of the synergistic degradation for antibiotic micropollutants in the Cu/ag‐C3N4 system. Photocatalytic processes driven by visible‐light irradiation offer a sustainable means of micropollutants removal from aquatic environments without the addition of reagents.
Xiaozhe Song +12 more
wiley +1 more source
A Modular Platform for Quantitative Two-Color Bioluminescence Combining NanoLuc and Red-Shifted NanoPrism Luciferases. [PDF]
Porter K +12 more
europepmc +1 more source
Application of the solvent effect on bioluminescent reporter bacteria as a real-time membrane toxicity assay. [PDF]
Myer PR, Turco RF, Applegate BM.
europepmc +1 more source
Clinical trials of chimeric antigen receptor T‐cell (CAR‐T) therapies in glioblastoma have shown limited clinical benefits. Whether this may be explained by the basal quality of CAR‐T products, which are currently generated using patient, autologous T‐cells, has been little explored.
Sabra K. Salim +22 more
wiley +1 more source

